fig2

 <i>Helicobacter pylori</i> is associated with a higher risk of MAFLD prevalence and all-cause mortality: results from the NHANES III follow-up study

Figure 2. Kaplan-Meier analysis comparing H. pylori-seropositive and seronegative participants. (A) Total population; (B) non-MAFLD group; and (C) MAFLD group. Log-rank test P-values are shown. H. pylori: Helicobacter pylori; MAFLD: metabolic dysfunction-associated fatty liver disease.

Hepatoma Research
ISSN 2454-2520 (Online) 2394-5079 (Print)

Portico

All published articles are preserved here permanently:

https://www.portico.org/publishers/oae/

Portico

All published articles are preserved here permanently:

https://www.portico.org/publishers/oae/